Low Neutrophil Count : Drugs
Print
Email
SaveHealthline's Premium Tools
Healthline Part D Plan Selector
Medicare's drug plans are subsidized by the US federal government and offered through insurers.
Advertisement
Marketplace
Drugs could include:
-
immune globulins
|
Neutropenia is an abnormally low level of neutrophils in the blood. Neutrophils are white blood cells (WBCs) produced in the bone marrow that ingest bacteria. Neutropenia is sometimes called agranulocytosis or granulocytopenia because neutrophils ...
|
|
Filgrastim is a medicine used to increase the white blood cell count in the body, which will help prevent infection. Filgrastim is known by the brand name Neupogen.
|
|
Biosynthetic hematopoietic agent that principally affects the proliferation and differentiation of neutrophils within the bone marrow and possibly other sites (e.g., spleen). Exerts same pharmacologic effects as endogenous granulocyte colony-stimulating factor (G-CSF).
|
|
Immune globulin is a concentrated solution of antibodies, pooled from donated blood, which is sometimes given to cancer patients whose own immune systems are either not working or are suppressed as a side effect of treatment. Immune globulin can also be called gamma globulin; in the United States some of the brand names are Gamimune, Gammagard, Gammar-P, Iveegam, Polygam, Sandoglobulin, and Venoglobulin.
|
|
Sargramostim is a protein that stimulates the production of white blood cells. Sargramostim
is similar a substance in the body called granulocyte-macrophage colony stimulating factor (GM-CSF).
|
|
Pegfilgrastim is a colony stimulating factor. It is a man-made form of a protein that
stimulates the growth of white blood cells called neutrophils in your body. White blood cells help
your body fight against infection.
|
|
Filgrastim is a man-made form of a protein that stimulates the growth of white blood cells
in your body. White blood cells help your body fight against infection.
|
|
Biosynthetic hematopoietic agent that principally affects the proliferation and differentiation of neutrophils within the bone marrow; a covalent conjugate of filgrastim (a human granulocyte colony-stimulating factor [G-CSF]) and monomethoxypolyethylene glycol (PEG).
|
|
Sargramostim is a medicine used to increase the blood cell counts after bone marrow transplants and chemotherapy . Sargramostim may be referred to as GM-CSF or granulocyte-macrophage colony stimulating factor.
|
|
Biosynthetic hematopoietic agent that affects the proliferation and differentiation of a variety of hematopoietic progenitor cells; a yeast-derived ( Saccharomyces cerevisiae ) recombinant human granulocyte-macrophage colony-stimulating factor (rHuGM-CSF). Exerts the pharmacologic effects usually produced by endogenous human GM-CSF.
|
 |
 |
Home | About | Health Experts | Careers | Site Map | Feedback | Help | Health Tools | Tell a Friend
Advertise | Terms of Use | Privacy Policy
Advertise | Terms of Use | Privacy Policy
Copyright © 2005 - 2008 Healthline Networks, Inc. All rights reserved.